Global Peripheral Drug-eluting Balloon Market Growth 2026-2032
The global Peripheral Drug-eluting Balloon market size is predicted to grow from US$ 793 million in 2025 to US$ 1777 million in 2032; it is expected to grow at a CAGR of 12.2% from 2026 to 2032.
Peripheral drug-eluting balloons (often referred to as peripheral drug-coated balloons, DCBs) are endovascular angioplasty balloons designed for peripheral arteries (commonly femoropopliteal segments), coated with an antiproliferative drug (typically paclitaxel or ?limus? agents) plus an excipient/carrier system. During inflation, they provide immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic concept is ?leave nothing behind,? aiming to avoid the long-term burden of permanent implants and preserve flexibility for future revascularization, increasingly combined with lesion preparation and intravascular imaging to enable more repeatable peripheral vascular repair pathways.In 2025, global Peripheral drug-eluting balloons production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.
Opportunities are anchored in the long-term shift toward minimally invasive, repair-centric peripheral interventions. A clearer safety boundary has strengthened adoption confidence: the U.S. FDA?s updated communication on paclitaxel-coated devices for PAD states that the totality of available evidence does not support an increased mortality risk, enabling more actionable hospital governance and pathway standardization. In parallel, leading companies explicitly position peripheral drug-coated balloons within their core peripheral intervention portfolios in annual reporting, signaling a transition from selective use to routine toolset adoption with ongoing room for technology iteration and category expansion.
The competitive bar is shifting from ?availability? to ?scalable reproducibility and compliant delivery.? As drug?device combination products, peripheral DCBs are highly sensitive to coating integrity, particulate control, dose consistency, and shelf-life stability?where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment and procurement reforms intensify the need to balance quality systems, supply assurance, and cost efficiency. In China, the National Healthcare Security Administration published the winning results for the national procurement of drug-coated balloons on January 14, 2026, accelerating a more rules-based, scale-driven market phase.
Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in peripheral disease elevate the importance of integrated optimization?lesion preparation, drug-transfer efficiency, and durable patency?driving more routine combination of DCBs with plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). Procurement implementation further encourages hospitals to formalize compliant pathways and device bundles, shifting growth from ?operator preference?driven? to ?pathway management?driven? adoption.
Upstream differentiation is ultimately an integrated ?materials?coating?validation? capability. Key inputs include balloon/catheter polymers and reinforcements, drug APIs (paclitaxel or limus agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. With procurement pressure and global compliance expectations in parallel, suppliers are increasingly evaluated on medical-grade traceability, clean manufacturing, and change control. The ability to industrialize coating consistency, yield, and batch-release stability as a platform capability directly determines scalable delivery efficiency and brand credibility.
LP Information, Inc. (LPI) ' newest research report, the ?Peripheral Drug-eluting Balloon Industry Forecast? looks at past sales and reviews total world Peripheral Drug-eluting Balloon sales in 2025, providing a comprehensive analysis by region and market sector of projected Peripheral Drug-eluting Balloon sales for 2026 through 2032. With Peripheral Drug-eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Drug-eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Drug-eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral Drug-eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Peripheral Drug-eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Drug-eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Drug-eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Drug-eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Peripheral drug-eluting balloons (often referred to as peripheral drug-coated balloons, DCBs) are endovascular angioplasty balloons designed for peripheral arteries (commonly femoropopliteal segments), coated with an antiproliferative drug (typically paclitaxel or ?limus? agents) plus an excipient/carrier system. During inflation, they provide immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic concept is ?leave nothing behind,? aiming to avoid the long-term burden of permanent implants and preserve flexibility for future revascularization, increasingly combined with lesion preparation and intravascular imaging to enable more repeatable peripheral vascular repair pathways.In 2025, global Peripheral drug-eluting balloons production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.
Opportunities are anchored in the long-term shift toward minimally invasive, repair-centric peripheral interventions. A clearer safety boundary has strengthened adoption confidence: the U.S. FDA?s updated communication on paclitaxel-coated devices for PAD states that the totality of available evidence does not support an increased mortality risk, enabling more actionable hospital governance and pathway standardization. In parallel, leading companies explicitly position peripheral drug-coated balloons within their core peripheral intervention portfolios in annual reporting, signaling a transition from selective use to routine toolset adoption with ongoing room for technology iteration and category expansion.
The competitive bar is shifting from ?availability? to ?scalable reproducibility and compliant delivery.? As drug?device combination products, peripheral DCBs are highly sensitive to coating integrity, particulate control, dose consistency, and shelf-life stability?where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment and procurement reforms intensify the need to balance quality systems, supply assurance, and cost efficiency. In China, the National Healthcare Security Administration published the winning results for the national procurement of drug-coated balloons on January 14, 2026, accelerating a more rules-based, scale-driven market phase.
Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in peripheral disease elevate the importance of integrated optimization?lesion preparation, drug-transfer efficiency, and durable patency?driving more routine combination of DCBs with plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). Procurement implementation further encourages hospitals to formalize compliant pathways and device bundles, shifting growth from ?operator preference?driven? to ?pathway management?driven? adoption.
Upstream differentiation is ultimately an integrated ?materials?coating?validation? capability. Key inputs include balloon/catheter polymers and reinforcements, drug APIs (paclitaxel or limus agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. With procurement pressure and global compliance expectations in parallel, suppliers are increasingly evaluated on medical-grade traceability, clean manufacturing, and change control. The ability to industrialize coating consistency, yield, and batch-release stability as a platform capability directly determines scalable delivery efficiency and brand credibility.
LP Information, Inc. (LPI) ' newest research report, the ?Peripheral Drug-eluting Balloon Industry Forecast? looks at past sales and reviews total world Peripheral Drug-eluting Balloon sales in 2025, providing a comprehensive analysis by region and market sector of projected Peripheral Drug-eluting Balloon sales for 2026 through 2032. With Peripheral Drug-eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Drug-eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Drug-eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral Drug-eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Peripheral Drug-eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Drug-eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Drug-eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Drug-eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Paclitaxel
- Others
- In-Stent Restenosi
- De Novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Lower Limbs
- Renal Artery
- Carotid Artery
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific
- BD
- Acotec
- Philips
- Lepu Medical
- Eurocor
- MicroPort Medical
- What is the 10-year outlook for the global Peripheral Drug-eluting Balloon market?
- What factors are driving Peripheral Drug-eluting Balloon market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doPeripheral Drug-eluting Balloon market opportunities vary by end market size?
- How does Peripheral Drug-eluting Balloon break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Drug-eluting Balloon Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Peripheral Drug-eluting Balloon by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Peripheral Drug-eluting Balloon by Country/Region, 2021, 2025 & 2032
2.2 Peripheral Drug-eluting Balloon Segment by Type
2.2.1 Paclitaxel
2.2.2 Others
2.2.3 Peripheral Drug-eluting Balloon Sales by Type
2.2.3.1 Global Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
2.2.3.2 Global Peripheral Drug-eluting Balloon Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Peripheral Drug-eluting Balloon Sale Price by Type (2021-2026)
2.3 Peripheral Drug-eluting Balloon Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Peripheral Drug-eluting Balloon Sales by Use Scenario
2.3.4.1 Global Peripheral Drug-eluting Balloon Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Peripheral Drug-eluting Balloon Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Peripheral Drug-eluting Balloon Sale Price by Use Scenario (2021-2026)
2.4 Peripheral Drug-eluting Balloon Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Peripheral Drug-eluting Balloon Sales by Balloon Platform Mechanics
2.4.4.1 Global Peripheral Drug-eluting Balloon Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Peripheral Drug-eluting Balloon Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Peripheral Drug-eluting Balloon Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Peripheral Drug-eluting Balloon Segment by Application
2.5.1 Lower Limbs
2.5.2 Renal Artery
2.5.3 Carotid Artery
2.5.4 Peripheral Drug-eluting Balloon Sales by Application
2.5.4.1 Global Peripheral Drug-eluting Balloon Sale Market Share by Application (2021-2026)
2.5.4.2 Global Peripheral Drug-eluting Balloon Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Peripheral Drug-eluting Balloon Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Peripheral Drug-eluting Balloon Breakdown Data by Company
3.1.1 Global Peripheral Drug-eluting Balloon Annual Sales by Company (2021-2026)
3.1.2 Global Peripheral Drug-eluting Balloon Sales Market Share by Company (2021-2026)
3.2 Global Peripheral Drug-eluting Balloon Annual Revenue by Company (2021-2026)
3.2.1 Global Peripheral Drug-eluting Balloon Revenue by Company (2021-2026)
3.2.2 Global Peripheral Drug-eluting Balloon Revenue Market Share by Company (2021-2026)
3.3 Global Peripheral Drug-eluting Balloon Sale Price by Company
3.4 Key Manufacturers Peripheral Drug-eluting Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Drug-eluting Balloon Product Location Distribution
3.4.2 Players Peripheral Drug-eluting Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERIPHERAL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Peripheral Drug-eluting Balloon Market Size by Geographic Region (2021-2026)
4.1.1 Global Peripheral Drug-eluting Balloon Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Peripheral Drug-eluting Balloon Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Peripheral Drug-eluting Balloon Market Size by Country/Region (2021-2026)
4.2.1 Global Peripheral Drug-eluting Balloon Annual Sales by Country/Region (2021-2026)
4.2.2 Global Peripheral Drug-eluting Balloon Annual Revenue by Country/Region (2021-2026)
4.3 Americas Peripheral Drug-eluting Balloon Sales Growth
4.4 APAC Peripheral Drug-eluting Balloon Sales Growth
4.5 Europe Peripheral Drug-eluting Balloon Sales Growth
4.6 Middle East & Africa Peripheral Drug-eluting Balloon Sales Growth
5 AMERICAS
5.1 Americas Peripheral Drug-eluting Balloon Sales by Country
5.1.1 Americas Peripheral Drug-eluting Balloon Sales by Country (2021-2026)
5.1.2 Americas Peripheral Drug-eluting Balloon Revenue by Country (2021-2026)
5.2 Americas Peripheral Drug-eluting Balloon Sales by Type (2021-2026)
5.3 Americas Peripheral Drug-eluting Balloon Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Drug-eluting Balloon Sales by Region
6.1.1 APAC Peripheral Drug-eluting Balloon Sales by Region (2021-2026)
6.1.2 APAC Peripheral Drug-eluting Balloon Revenue by Region (2021-2026)
6.2 APAC Peripheral Drug-eluting Balloon Sales by Type (2021-2026)
6.3 APAC Peripheral Drug-eluting Balloon Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peripheral Drug-eluting Balloon by Country
7.1.1 Europe Peripheral Drug-eluting Balloon Sales by Country (2021-2026)
7.1.2 Europe Peripheral Drug-eluting Balloon Revenue by Country (2021-2026)
7.2 Europe Peripheral Drug-eluting Balloon Sales by Type (2021-2026)
7.3 Europe Peripheral Drug-eluting Balloon Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Drug-eluting Balloon by Country
8.1.1 Middle East & Africa Peripheral Drug-eluting Balloon Sales by Country (2021-2026)
8.1.2 Middle East & Africa Peripheral Drug-eluting Balloon Revenue by Country (2021-2026)
8.2 Middle East & Africa Peripheral Drug-eluting Balloon Sales by Type (2021-2026)
8.3 Middle East & Africa Peripheral Drug-eluting Balloon Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Drug-eluting Balloon
10.3 Manufacturing Process Analysis of Peripheral Drug-eluting Balloon
10.4 Industry Chain Structure of Peripheral Drug-eluting Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Drug-eluting Balloon Distributors
11.3 Peripheral Drug-eluting Balloon Customer
12 WORLD FORECAST REVIEW FOR PERIPHERAL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
12.1 Global Peripheral Drug-eluting Balloon Market Size Forecast by Region
12.1.1 Global Peripheral Drug-eluting Balloon Forecast by Region (2027-2032)
12.1.2 Global Peripheral Drug-eluting Balloon Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Peripheral Drug-eluting Balloon Forecast by Type (2027-2032)
12.7 Global Peripheral Drug-eluting Balloon Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.1.3 Medtronic Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.2.3 Boston Scientific Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.3.3 BD Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Acotec
13.4.1 Acotec Company Information
13.4.2 Acotec Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.4.3 Acotec Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Acotec Main Business Overview
13.4.5 Acotec Latest Developments
13.5 Philips
13.5.1 Philips Company Information
13.5.2 Philips Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.5.3 Philips Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Philips Main Business Overview
13.5.5 Philips Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.6.3 Lepu Medical Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.7.3 Eurocor Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 MicroPort Medical
13.8.1 MicroPort Medical Company Information
13.8.2 MicroPort Medical Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.8.3 MicroPort Medical Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MicroPort Medical Main Business Overview
13.8.5 MicroPort Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Drug-eluting Balloon Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Peripheral Drug-eluting Balloon by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Peripheral Drug-eluting Balloon by Country/Region, 2021, 2025 & 2032
2.2 Peripheral Drug-eluting Balloon Segment by Type
2.2.1 Paclitaxel
2.2.2 Others
2.2.3 Peripheral Drug-eluting Balloon Sales by Type
2.2.3.1 Global Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
2.2.3.2 Global Peripheral Drug-eluting Balloon Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Peripheral Drug-eluting Balloon Sale Price by Type (2021-2026)
2.3 Peripheral Drug-eluting Balloon Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Peripheral Drug-eluting Balloon Sales by Use Scenario
2.3.4.1 Global Peripheral Drug-eluting Balloon Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Peripheral Drug-eluting Balloon Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Peripheral Drug-eluting Balloon Sale Price by Use Scenario (2021-2026)
2.4 Peripheral Drug-eluting Balloon Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Peripheral Drug-eluting Balloon Sales by Balloon Platform Mechanics
2.4.4.1 Global Peripheral Drug-eluting Balloon Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Peripheral Drug-eluting Balloon Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Peripheral Drug-eluting Balloon Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Peripheral Drug-eluting Balloon Segment by Application
2.5.1 Lower Limbs
2.5.2 Renal Artery
2.5.3 Carotid Artery
2.5.4 Peripheral Drug-eluting Balloon Sales by Application
2.5.4.1 Global Peripheral Drug-eluting Balloon Sale Market Share by Application (2021-2026)
2.5.4.2 Global Peripheral Drug-eluting Balloon Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Peripheral Drug-eluting Balloon Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Peripheral Drug-eluting Balloon Breakdown Data by Company
3.1.1 Global Peripheral Drug-eluting Balloon Annual Sales by Company (2021-2026)
3.1.2 Global Peripheral Drug-eluting Balloon Sales Market Share by Company (2021-2026)
3.2 Global Peripheral Drug-eluting Balloon Annual Revenue by Company (2021-2026)
3.2.1 Global Peripheral Drug-eluting Balloon Revenue by Company (2021-2026)
3.2.2 Global Peripheral Drug-eluting Balloon Revenue Market Share by Company (2021-2026)
3.3 Global Peripheral Drug-eluting Balloon Sale Price by Company
3.4 Key Manufacturers Peripheral Drug-eluting Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Drug-eluting Balloon Product Location Distribution
3.4.2 Players Peripheral Drug-eluting Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERIPHERAL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Peripheral Drug-eluting Balloon Market Size by Geographic Region (2021-2026)
4.1.1 Global Peripheral Drug-eluting Balloon Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Peripheral Drug-eluting Balloon Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Peripheral Drug-eluting Balloon Market Size by Country/Region (2021-2026)
4.2.1 Global Peripheral Drug-eluting Balloon Annual Sales by Country/Region (2021-2026)
4.2.2 Global Peripheral Drug-eluting Balloon Annual Revenue by Country/Region (2021-2026)
4.3 Americas Peripheral Drug-eluting Balloon Sales Growth
4.4 APAC Peripheral Drug-eluting Balloon Sales Growth
4.5 Europe Peripheral Drug-eluting Balloon Sales Growth
4.6 Middle East & Africa Peripheral Drug-eluting Balloon Sales Growth
5 AMERICAS
5.1 Americas Peripheral Drug-eluting Balloon Sales by Country
5.1.1 Americas Peripheral Drug-eluting Balloon Sales by Country (2021-2026)
5.1.2 Americas Peripheral Drug-eluting Balloon Revenue by Country (2021-2026)
5.2 Americas Peripheral Drug-eluting Balloon Sales by Type (2021-2026)
5.3 Americas Peripheral Drug-eluting Balloon Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Drug-eluting Balloon Sales by Region
6.1.1 APAC Peripheral Drug-eluting Balloon Sales by Region (2021-2026)
6.1.2 APAC Peripheral Drug-eluting Balloon Revenue by Region (2021-2026)
6.2 APAC Peripheral Drug-eluting Balloon Sales by Type (2021-2026)
6.3 APAC Peripheral Drug-eluting Balloon Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peripheral Drug-eluting Balloon by Country
7.1.1 Europe Peripheral Drug-eluting Balloon Sales by Country (2021-2026)
7.1.2 Europe Peripheral Drug-eluting Balloon Revenue by Country (2021-2026)
7.2 Europe Peripheral Drug-eluting Balloon Sales by Type (2021-2026)
7.3 Europe Peripheral Drug-eluting Balloon Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Drug-eluting Balloon by Country
8.1.1 Middle East & Africa Peripheral Drug-eluting Balloon Sales by Country (2021-2026)
8.1.2 Middle East & Africa Peripheral Drug-eluting Balloon Revenue by Country (2021-2026)
8.2 Middle East & Africa Peripheral Drug-eluting Balloon Sales by Type (2021-2026)
8.3 Middle East & Africa Peripheral Drug-eluting Balloon Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Drug-eluting Balloon
10.3 Manufacturing Process Analysis of Peripheral Drug-eluting Balloon
10.4 Industry Chain Structure of Peripheral Drug-eluting Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Drug-eluting Balloon Distributors
11.3 Peripheral Drug-eluting Balloon Customer
12 WORLD FORECAST REVIEW FOR PERIPHERAL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
12.1 Global Peripheral Drug-eluting Balloon Market Size Forecast by Region
12.1.1 Global Peripheral Drug-eluting Balloon Forecast by Region (2027-2032)
12.1.2 Global Peripheral Drug-eluting Balloon Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Peripheral Drug-eluting Balloon Forecast by Type (2027-2032)
12.7 Global Peripheral Drug-eluting Balloon Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.1.3 Medtronic Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.2.3 Boston Scientific Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.3.3 BD Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Acotec
13.4.1 Acotec Company Information
13.4.2 Acotec Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.4.3 Acotec Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Acotec Main Business Overview
13.4.5 Acotec Latest Developments
13.5 Philips
13.5.1 Philips Company Information
13.5.2 Philips Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.5.3 Philips Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Philips Main Business Overview
13.5.5 Philips Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.6.3 Lepu Medical Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.7.3 Eurocor Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 MicroPort Medical
13.8.1 MicroPort Medical Company Information
13.8.2 MicroPort Medical Peripheral Drug-eluting Balloon Product Portfolios and Specifications
13.8.3 MicroPort Medical Peripheral Drug-eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MicroPort Medical Main Business Overview
13.8.5 MicroPort Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peripheral Drug-eluting Balloon Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Peripheral Drug-eluting Balloon Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Paclitaxel
Table 4. Major Players of Others
Table 5. Global Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 6. Global Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Table 7. Global Peripheral Drug-eluting Balloon Revenue by Type (2021-2026) & ($ million)
Table 8. Global Peripheral Drug-eluting Balloon Revenue Market Share by Type (2021-2026)
Table 9. Global Peripheral Drug-eluting Balloon Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Peripheral Drug-eluting Balloon Sales by Use Scenario (2021-2026) & (K Units)
Table 14. Global Peripheral Drug-eluting Balloon Sales Market Share by Use Scenario (2021-2026)
Table 15. Global Peripheral Drug-eluting Balloon Revenue by Use Scenario (2021-2026) & ($ million)
Table 16. Global Peripheral Drug-eluting Balloon Revenue Market Share by Use Scenario (2021-2026)
Table 17. Global Peripheral Drug-eluting Balloon Sale Price by Use Scenario (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Peripheral Drug-eluting Balloon Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 22. Global Peripheral Drug-eluting Balloon Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 23. Global Peripheral Drug-eluting Balloon Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 24. Global Peripheral Drug-eluting Balloon Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 25. Global Peripheral Drug-eluting Balloon Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 26. Global Peripheral Drug-eluting Balloon Sale by Application (2021-2026) & (K Units)
Table 27. Global Peripheral Drug-eluting Balloon Sale Market Share by Application (2021-2026)
Table 28. Global Peripheral Drug-eluting Balloon Revenue by Application (2021-2026) & ($ million)
Table 29. Global Peripheral Drug-eluting Balloon Revenue Market Share by Application (2021-2026)
Table 30. Global Peripheral Drug-eluting Balloon Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Peripheral Drug-eluting Balloon Sales by Company (2021-2026) & (K Units)
Table 32. Global Peripheral Drug-eluting Balloon Sales Market Share by Company (2021-2026)
Table 33. Global Peripheral Drug-eluting Balloon Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Peripheral Drug-eluting Balloon Revenue Market Share by Company (2021-2026)
Table 35. Global Peripheral Drug-eluting Balloon Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Peripheral Drug-eluting Balloon Producing Area Distribution and Sales Area
Table 37. Players Peripheral Drug-eluting Balloon Products Offered
Table 38. Peripheral Drug-eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Peripheral Drug-eluting Balloon Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Peripheral Drug-eluting Balloon Sales Market Share Geographic Region (2021-2026)
Table 43. Global Peripheral Drug-eluting Balloon Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Peripheral Drug-eluting Balloon Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Peripheral Drug-eluting Balloon Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Peripheral Drug-eluting Balloon Sales Market Share by Country/Region (2021-2026)
Table 47. Global Peripheral Drug-eluting Balloon Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Peripheral Drug-eluting Balloon Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Peripheral Drug-eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 50. Americas Peripheral Drug-eluting Balloon Sales Market Share by Country (2021-2026)
Table 51. Americas Peripheral Drug-eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 53. Americas Peripheral Drug-eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 54. APAC Peripheral Drug-eluting Balloon Sales by Region (2021-2026) & (K Units)
Table 55. APAC Peripheral Drug-eluting Balloon Sales Market Share by Region (2021-2026)
Table 56. APAC Peripheral Drug-eluting Balloon Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 58. APAC Peripheral Drug-eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 59. Europe Peripheral Drug-eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 60. Europe Peripheral Drug-eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 62. Europe Peripheral Drug-eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Peripheral Drug-eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Peripheral Drug-eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Peripheral Drug-eluting Balloon
Table 68. Key Market Challenges & Risks of Peripheral Drug-eluting Balloon
Table 69. Key Industry Trends of Peripheral Drug-eluting Balloon
Table 70. Peripheral Drug-eluting Balloon Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Peripheral Drug-eluting Balloon Distributors List
Table 73. Peripheral Drug-eluting Balloon Customer List
Table 74. Global Peripheral Drug-eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Peripheral Drug-eluting Balloon Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Peripheral Drug-eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Peripheral Drug-eluting Balloon Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Peripheral Drug-eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Peripheral Drug-eluting Balloon Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Peripheral Drug-eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Peripheral Drug-eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Peripheral Drug-eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Peripheral Drug-eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Peripheral Drug-eluting Balloon Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Peripheral Drug-eluting Balloon Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Peripheral Drug-eluting Balloon Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Peripheral Drug-eluting Balloon Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Medtronic Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 90. Medtronic Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Medtronic Main Business
Table 92. Medtronic Latest Developments
Table 93. Boston Scientific Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 94. Boston Scientific Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 95. Boston Scientific Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Boston Scientific Main Business
Table 97. Boston Scientific Latest Developments
Table 98. BD Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 99. BD Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 100. BD Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. BD Main Business
Table 102. BD Latest Developments
Table 103. Acotec Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 104. Acotec Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 105. Acotec Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Acotec Main Business
Table 107. Acotec Latest Developments
Table 108. Philips Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 109. Philips Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 110. Philips Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Philips Main Business
Table 112. Philips Latest Developments
Table 113. Lepu Medical Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 114. Lepu Medical Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 115. Lepu Medical Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lepu Medical Main Business
Table 117. Lepu Medical Latest Developments
Table 118. Eurocor Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 119. Eurocor Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 120. Eurocor Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Eurocor Main Business
Table 122. Eurocor Latest Developments
Table 123. MicroPort Medical Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 124. MicroPort Medical Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 125. MicroPort Medical Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. MicroPort Medical Main Business
Table 127. MicroPort Medical Latest Developments
Table 1. Peripheral Drug-eluting Balloon Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Peripheral Drug-eluting Balloon Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Paclitaxel
Table 4. Major Players of Others
Table 5. Global Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 6. Global Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Table 7. Global Peripheral Drug-eluting Balloon Revenue by Type (2021-2026) & ($ million)
Table 8. Global Peripheral Drug-eluting Balloon Revenue Market Share by Type (2021-2026)
Table 9. Global Peripheral Drug-eluting Balloon Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Peripheral Drug-eluting Balloon Sales by Use Scenario (2021-2026) & (K Units)
Table 14. Global Peripheral Drug-eluting Balloon Sales Market Share by Use Scenario (2021-2026)
Table 15. Global Peripheral Drug-eluting Balloon Revenue by Use Scenario (2021-2026) & ($ million)
Table 16. Global Peripheral Drug-eluting Balloon Revenue Market Share by Use Scenario (2021-2026)
Table 17. Global Peripheral Drug-eluting Balloon Sale Price by Use Scenario (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Peripheral Drug-eluting Balloon Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 22. Global Peripheral Drug-eluting Balloon Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 23. Global Peripheral Drug-eluting Balloon Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 24. Global Peripheral Drug-eluting Balloon Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 25. Global Peripheral Drug-eluting Balloon Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 26. Global Peripheral Drug-eluting Balloon Sale by Application (2021-2026) & (K Units)
Table 27. Global Peripheral Drug-eluting Balloon Sale Market Share by Application (2021-2026)
Table 28. Global Peripheral Drug-eluting Balloon Revenue by Application (2021-2026) & ($ million)
Table 29. Global Peripheral Drug-eluting Balloon Revenue Market Share by Application (2021-2026)
Table 30. Global Peripheral Drug-eluting Balloon Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Peripheral Drug-eluting Balloon Sales by Company (2021-2026) & (K Units)
Table 32. Global Peripheral Drug-eluting Balloon Sales Market Share by Company (2021-2026)
Table 33. Global Peripheral Drug-eluting Balloon Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Peripheral Drug-eluting Balloon Revenue Market Share by Company (2021-2026)
Table 35. Global Peripheral Drug-eluting Balloon Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Peripheral Drug-eluting Balloon Producing Area Distribution and Sales Area
Table 37. Players Peripheral Drug-eluting Balloon Products Offered
Table 38. Peripheral Drug-eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Peripheral Drug-eluting Balloon Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Peripheral Drug-eluting Balloon Sales Market Share Geographic Region (2021-2026)
Table 43. Global Peripheral Drug-eluting Balloon Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Peripheral Drug-eluting Balloon Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Peripheral Drug-eluting Balloon Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Peripheral Drug-eluting Balloon Sales Market Share by Country/Region (2021-2026)
Table 47. Global Peripheral Drug-eluting Balloon Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Peripheral Drug-eluting Balloon Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Peripheral Drug-eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 50. Americas Peripheral Drug-eluting Balloon Sales Market Share by Country (2021-2026)
Table 51. Americas Peripheral Drug-eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 53. Americas Peripheral Drug-eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 54. APAC Peripheral Drug-eluting Balloon Sales by Region (2021-2026) & (K Units)
Table 55. APAC Peripheral Drug-eluting Balloon Sales Market Share by Region (2021-2026)
Table 56. APAC Peripheral Drug-eluting Balloon Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 58. APAC Peripheral Drug-eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 59. Europe Peripheral Drug-eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 60. Europe Peripheral Drug-eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 62. Europe Peripheral Drug-eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Peripheral Drug-eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Peripheral Drug-eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Peripheral Drug-eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Peripheral Drug-eluting Balloon
Table 68. Key Market Challenges & Risks of Peripheral Drug-eluting Balloon
Table 69. Key Industry Trends of Peripheral Drug-eluting Balloon
Table 70. Peripheral Drug-eluting Balloon Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Peripheral Drug-eluting Balloon Distributors List
Table 73. Peripheral Drug-eluting Balloon Customer List
Table 74. Global Peripheral Drug-eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Peripheral Drug-eluting Balloon Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Peripheral Drug-eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Peripheral Drug-eluting Balloon Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Peripheral Drug-eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Peripheral Drug-eluting Balloon Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Peripheral Drug-eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Peripheral Drug-eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Peripheral Drug-eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Peripheral Drug-eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Peripheral Drug-eluting Balloon Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Peripheral Drug-eluting Balloon Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Peripheral Drug-eluting Balloon Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Peripheral Drug-eluting Balloon Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Medtronic Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 90. Medtronic Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Medtronic Main Business
Table 92. Medtronic Latest Developments
Table 93. Boston Scientific Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 94. Boston Scientific Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 95. Boston Scientific Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Boston Scientific Main Business
Table 97. Boston Scientific Latest Developments
Table 98. BD Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 99. BD Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 100. BD Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. BD Main Business
Table 102. BD Latest Developments
Table 103. Acotec Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 104. Acotec Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 105. Acotec Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Acotec Main Business
Table 107. Acotec Latest Developments
Table 108. Philips Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 109. Philips Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 110. Philips Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Philips Main Business
Table 112. Philips Latest Developments
Table 113. Lepu Medical Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 114. Lepu Medical Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 115. Lepu Medical Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lepu Medical Main Business
Table 117. Lepu Medical Latest Developments
Table 118. Eurocor Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 119. Eurocor Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 120. Eurocor Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Eurocor Main Business
Table 122. Eurocor Latest Developments
Table 123. MicroPort Medical Basic Information, Peripheral Drug-eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 124. MicroPort Medical Peripheral Drug-eluting Balloon Product Portfolios and Specifications
Table 125. MicroPort Medical Peripheral Drug-eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. MicroPort Medical Main Business
Table 127. MicroPort Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Peripheral Drug-eluting Balloon
Figure 2. Peripheral Drug-eluting Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Drug-eluting Balloon Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Peripheral Drug-eluting Balloon Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Peripheral Drug-eluting Balloon Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Peripheral Drug-eluting Balloon Sales Market Share by Country/Region (2025)
Figure 10. Peripheral Drug-eluting Balloon Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Paclitaxel
Figure 12. Product Picture of Others
Figure 13. Global Peripheral Drug-eluting Balloon Sales Market Share by Type in 2026
Figure 14. Global Peripheral Drug-eluting Balloon Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Peripheral Drug-eluting Balloon Sales Market Share by Use Scenario in 2026
Figure 19. Global Peripheral Drug-eluting Balloon Revenue Market Share by Use Scenario (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Global Peripheral Drug-eluting Balloon Sales Market Share by Balloon Platform Mechanics in 2026
Figure 24. Global Peripheral Drug-eluting Balloon Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 25. Peripheral Drug-eluting Balloon Consumed in Lower Limbs
Figure 26. Global Peripheral Drug-eluting Balloon Market: Lower Limbs (2021-2026) & (K Units)
Figure 27. Peripheral Drug-eluting Balloon Consumed in Renal Artery
Figure 28. Global Peripheral Drug-eluting Balloon Market: Renal Artery (2021-2026) & (K Units)
Figure 29. Peripheral Drug-eluting Balloon Consumed in Carotid Artery
Figure 30. Global Peripheral Drug-eluting Balloon Market: Carotid Artery (2021-2026) & (K Units)
Figure 31. Global Peripheral Drug-eluting Balloon Sale Market Share by Application (2025)
Figure 32. Global Peripheral Drug-eluting Balloon Revenue Market Share by Application in 2026
Figure 33. Peripheral Drug-eluting Balloon Sales by Company in 2026 (K Units)
Figure 34. Global Peripheral Drug-eluting Balloon Sales Market Share by Company in 2026
Figure 35. Peripheral Drug-eluting Balloon Revenue by Company in 2026 ($ millions)
Figure 36. Global Peripheral Drug-eluting Balloon Revenue Market Share by Company in 2026
Figure 37. Global Peripheral Drug-eluting Balloon Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Peripheral Drug-eluting Balloon Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Peripheral Drug-eluting Balloon Sales 2021-2026 (K Units)
Figure 40. Americas Peripheral Drug-eluting Balloon Revenue 2021-2026 ($ millions)
Figure 41. APAC Peripheral Drug-eluting Balloon Sales 2021-2026 (K Units)
Figure 42. APAC Peripheral Drug-eluting Balloon Revenue 2021-2026 ($ millions)
Figure 43. Europe Peripheral Drug-eluting Balloon Sales 2021-2026 (K Units)
Figure 44. Europe Peripheral Drug-eluting Balloon Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Peripheral Drug-eluting Balloon Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Peripheral Drug-eluting Balloon Revenue 2021-2026 ($ millions)
Figure 47. Americas Peripheral Drug-eluting Balloon Sales Market Share by Country in 2026
Figure 48. Americas Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 49. Americas Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Figure 50. Americas Peripheral Drug-eluting Balloon Sales Market Share by Application (2021-2026)
Figure 51. United States Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Peripheral Drug-eluting Balloon Sales Market Share by Region in 2026
Figure 56. APAC Peripheral Drug-eluting Balloon Revenue Market Share by Region (2021-2026)
Figure 57. APAC Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Figure 58. APAC Peripheral Drug-eluting Balloon Sales Market Share by Application (2021-2026)
Figure 59. China Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 63. India Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Peripheral Drug-eluting Balloon Sales Market Share by Country in 2026
Figure 67. Europe Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 68. Europe Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Figure 69. Europe Peripheral Drug-eluting Balloon Sales Market Share by Application (2021-2026)
Figure 70. Germany Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 71. France Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Peripheral Drug-eluting Balloon Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Peripheral Drug-eluting Balloon Sales Market Share by Application (2021-2026)
Figure 78. Egypt Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Peripheral Drug-eluting Balloon in 2026
Figure 84. Manufacturing Process Analysis of Peripheral Drug-eluting Balloon
Figure 85. Industry Chain Structure of Peripheral Drug-eluting Balloon
Figure 86. Channels of Distribution
Figure 87. Global Peripheral Drug-eluting Balloon Sales Market Forecast by Region (2027-2032)
Figure 88. Global Peripheral Drug-eluting Balloon Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Peripheral Drug-eluting Balloon Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Peripheral Drug-eluting Balloon Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Peripheral Drug-eluting Balloon Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Peripheral Drug-eluting Balloon Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Peripheral Drug-eluting Balloon
Figure 2. Peripheral Drug-eluting Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Drug-eluting Balloon Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Peripheral Drug-eluting Balloon Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Peripheral Drug-eluting Balloon Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Peripheral Drug-eluting Balloon Sales Market Share by Country/Region (2025)
Figure 10. Peripheral Drug-eluting Balloon Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Paclitaxel
Figure 12. Product Picture of Others
Figure 13. Global Peripheral Drug-eluting Balloon Sales Market Share by Type in 2026
Figure 14. Global Peripheral Drug-eluting Balloon Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Peripheral Drug-eluting Balloon Sales Market Share by Use Scenario in 2026
Figure 19. Global Peripheral Drug-eluting Balloon Revenue Market Share by Use Scenario (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Global Peripheral Drug-eluting Balloon Sales Market Share by Balloon Platform Mechanics in 2026
Figure 24. Global Peripheral Drug-eluting Balloon Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 25. Peripheral Drug-eluting Balloon Consumed in Lower Limbs
Figure 26. Global Peripheral Drug-eluting Balloon Market: Lower Limbs (2021-2026) & (K Units)
Figure 27. Peripheral Drug-eluting Balloon Consumed in Renal Artery
Figure 28. Global Peripheral Drug-eluting Balloon Market: Renal Artery (2021-2026) & (K Units)
Figure 29. Peripheral Drug-eluting Balloon Consumed in Carotid Artery
Figure 30. Global Peripheral Drug-eluting Balloon Market: Carotid Artery (2021-2026) & (K Units)
Figure 31. Global Peripheral Drug-eluting Balloon Sale Market Share by Application (2025)
Figure 32. Global Peripheral Drug-eluting Balloon Revenue Market Share by Application in 2026
Figure 33. Peripheral Drug-eluting Balloon Sales by Company in 2026 (K Units)
Figure 34. Global Peripheral Drug-eluting Balloon Sales Market Share by Company in 2026
Figure 35. Peripheral Drug-eluting Balloon Revenue by Company in 2026 ($ millions)
Figure 36. Global Peripheral Drug-eluting Balloon Revenue Market Share by Company in 2026
Figure 37. Global Peripheral Drug-eluting Balloon Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Peripheral Drug-eluting Balloon Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Peripheral Drug-eluting Balloon Sales 2021-2026 (K Units)
Figure 40. Americas Peripheral Drug-eluting Balloon Revenue 2021-2026 ($ millions)
Figure 41. APAC Peripheral Drug-eluting Balloon Sales 2021-2026 (K Units)
Figure 42. APAC Peripheral Drug-eluting Balloon Revenue 2021-2026 ($ millions)
Figure 43. Europe Peripheral Drug-eluting Balloon Sales 2021-2026 (K Units)
Figure 44. Europe Peripheral Drug-eluting Balloon Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Peripheral Drug-eluting Balloon Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Peripheral Drug-eluting Balloon Revenue 2021-2026 ($ millions)
Figure 47. Americas Peripheral Drug-eluting Balloon Sales Market Share by Country in 2026
Figure 48. Americas Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 49. Americas Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Figure 50. Americas Peripheral Drug-eluting Balloon Sales Market Share by Application (2021-2026)
Figure 51. United States Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Peripheral Drug-eluting Balloon Sales Market Share by Region in 2026
Figure 56. APAC Peripheral Drug-eluting Balloon Revenue Market Share by Region (2021-2026)
Figure 57. APAC Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Figure 58. APAC Peripheral Drug-eluting Balloon Sales Market Share by Application (2021-2026)
Figure 59. China Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 63. India Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Peripheral Drug-eluting Balloon Sales Market Share by Country in 2026
Figure 67. Europe Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 68. Europe Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Figure 69. Europe Peripheral Drug-eluting Balloon Sales Market Share by Application (2021-2026)
Figure 70. Germany Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 71. France Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Peripheral Drug-eluting Balloon Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Peripheral Drug-eluting Balloon Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Peripheral Drug-eluting Balloon Sales Market Share by Application (2021-2026)
Figure 78. Egypt Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Peripheral Drug-eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Peripheral Drug-eluting Balloon in 2026
Figure 84. Manufacturing Process Analysis of Peripheral Drug-eluting Balloon
Figure 85. Industry Chain Structure of Peripheral Drug-eluting Balloon
Figure 86. Channels of Distribution
Figure 87. Global Peripheral Drug-eluting Balloon Sales Market Forecast by Region (2027-2032)
Figure 88. Global Peripheral Drug-eluting Balloon Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Peripheral Drug-eluting Balloon Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Peripheral Drug-eluting Balloon Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Peripheral Drug-eluting Balloon Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Peripheral Drug-eluting Balloon Revenue Market Share Forecast by Application (2027-2032)
